Introduction: Idiopathic inflammatory myopathies have a reported incidence of 0.1 to 1 per
100,000 person‐years and prevalence of 0.55 to 6 per 100,000 in the United States. Methods: …

Background and aims Elevated low-density lipoprotein cholesterol (LDL-C) is a causal risk
factor for cardiovascular (CV) events. European guidelines recommend reducing LDL-C as …

Background Pulmonary arterial hypertension (PAH) is a rare condition that can ultimately
lead to right heart failure and death. In this study we estimated the health care costs and …

Objective. To estimate the incidence and prevalence of systemic sclerosis (SSc) in a large
US managed care organization (MCO) database. Methods. Subjects with claims-based …

Background and purpose Sickle cell disease (SCD) is a collection of rare inherited blood
disorders affecting approximately 100,000 people in the US and 20–25 million people globally. …

Background and aims Statin utilization and lipid goal achievement were estimated in a large
sample of Italian patients at high/very-high cardiovascular (CV) risk. Methods Patients aged …

Objective National estimates of atherosclerotic cardiovascular disease (ASCVD) in the
United States (US) are scarce, especially for patients grouped by cardiovascular risk, lipid-…

Objective. Systemic sclerosis (SSc) is a chronic autoimmune disease. The objective of our
study was to estimate the medical costs and healthcare resource use of subjects with SSc in a …

Objective: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can
affect multiple organ systems, including the kidneys (lupus nephritis) and the central nervous …

Introduction: In this study we determined the health‐care costs and resource utilization
associated with idiopathic inflammatory myopathies (IIMs) in a large managed care plan in the …